129 related articles for article (PubMed ID: 29700680)
1. Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.
Prieto R; Pascual JM
Pituitary; 2018 Aug; 21(4):431-442. PubMed ID: 29700680
[TBL] [Abstract][Full Text] [Related]
2. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
Fujio S; Hanaya R
No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344
[TBL] [Abstract][Full Text] [Related]
3. Biological Behaviour of Craniopharyngiomas.
Martinez-Barbera JP; Andoniadou CL
Neuroendocrinology; 2020; 110(9-10):797-804. PubMed ID: 32126562
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract][Full Text] [Related]
5. Genomic drivers in craniopharyngiomas: Analysis of the AACR project GENIE database.
Lehrich MB; Tong CLC; Hsu PKF; Kuan CE
Childs Nerv Syst; 2024 Jun; 40(6):1661-1669. PubMed ID: 38421446
[TBL] [Abstract][Full Text] [Related]
6. CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma.
Apps JR; Stache C; Gonzalez-Meljem JM; Gutteridge A; Chalker J; Jacques TS; Forshew T; Hölsken A; Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):510-514. PubMed ID: 32125720
[No Abstract] [Full Text] [Related]
7. Current Advances in Papillary Craniopharyngioma: State-Of-The-Art Therapies and Overview of the Literature.
Jannelli G; Calvanese F; Paun L; Raverot G; Jouanneau E
Brain Sci; 2023 Mar; 13(3):. PubMed ID: 36979325
[TBL] [Abstract][Full Text] [Related]
8. Advances in the management of craniopharyngioma.
O'steen L; Indelicato DJ
F1000Res; 2018; 7():. PubMed ID: 30363774
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic support in pediatric craniopharyngioma using deep learning.
Castiglioni G; Vallejos J; Intriago J; Hernández MI; Valenzuela S; Fernández J; Castro I; Valenzuela S; Estévez PA; Okuma C
Childs Nerv Syst; 2024 Apr; ():. PubMed ID: 38647660
[TBL] [Abstract][Full Text] [Related]
10. Predictive Factors for Pediatric Craniopharyngioma Recurrence: An Extensive Narrative Review.
Serbis A; Tsinopoulou VR; Papadopoulou A; Kolanis S; Sakellari EI; Margaritis K; Litou E; Ntouma S; Giza S; Kotanidou EP; Galli-Tsinopoulou A
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174978
[TBL] [Abstract][Full Text] [Related]
11. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of Craniopharyngioma.
Tang M; Chen C; Wang G; Wang Y; Zhang Z; Li H; Lu Q; Wang Z; Zhao S; Yang C; Zhong K; Zhang R; Guo L; Yuan Z; Nie C; Tong A
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551172
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis and validation of the critical genes associated with adamantinomatous craniopharyngioma.
Fang C; Zhou L; Huang H; Xu HT; Hong T; Zheng SY
Front Oncol; 2022; 12():1007236. PubMed ID: 36387067
[TBL] [Abstract][Full Text] [Related]
14. Duct-like diverticulum at the base of third ventricle tumors: a morphological signature diagnostic of papillary craniopharyngioma.
Pascual JM; Prieto R; Carrasco R; Barrios L
Neurosurg Rev; 2022 Oct; 45(5):3361-3379. PubMed ID: 35982344
[TBL] [Abstract][Full Text] [Related]
15. Pathological and Prognostic Characterization of Craniopharyngioma Based on the Expression of TrkA, β-Catenin, Cell Cycle Markers, and BRAF V600E Mutation.
Xu C; Ge S; Cheng J; Gao H; Zhang F; Han A
Front Endocrinol (Lausanne); 2022; 13():859381. PubMed ID: 35707464
[TBL] [Abstract][Full Text] [Related]
16. Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.
Pascual JM; Prieto R
Front Oncol; 2022; 12():872689. PubMed ID: 35392218
[No Abstract] [Full Text] [Related]
17. Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.
Martínez-Ortega A; Flores-Martinez Á; Venegas-Moreno E; Dios E; Del Can D; Rivas E; Kaen A; Cárdenas Ruiz-Valdepeñas E; Fajardo E; Roldán F; González-Rivera N; Oliva R; Fernández-Peña JI; Soto-Moreno A; Cano DA
J Clin Med; 2022 Jan; 11(1):. PubMed ID: 35012020
[TBL] [Abstract][Full Text] [Related]
18. Sporadic adamantinomatous craniopharyngioma with double-hit somatic APC mutations.
Hong CS; Omuro A; An Y; Inzucchi SE; Kohli AA; McGuone D; Vining EM; Omay SB; Erson-Omay EZ
Neurooncol Adv; 2021; 3(1):vdab124. PubMed ID: 34549183
[No Abstract] [Full Text] [Related]
19. Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases.
Prieto R; Barrios L; Pascual JM
Neurosurg Rev; 2022 Feb; 45(1):375-394. PubMed ID: 34448081
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
